reported that compared to model group, a combination of astragalus polysaccharide with cisplatin and adriamycin could significantly reduce the expressions of Ki-67, HIF-1α and VEGF, and had a significant synergistic and toxic effect on inhibition of tumor growth (168). Here, VEGFA is linked to neoplasm.